Age-Associated KLF9 Enhances the Inflammatory Response of Alveolar Macrophages Via Regulating TLR2 Expression

Chun Shen1, Haiyan Wang1

  • 1Department of Neonatology, Cangzhou Central Hospital, Cangzhou, China.

Rejuvenation Research
|December 8, 2023
PubMed

Insights

Krueppel-like factor 9 (KLF9) deficiency improves outcomes in Staphylococcus aureus pneumonia by reducing Toll-like receptor 2 (TLR2)-mediated inflammation. This suggests KLF9 is a potential therapeutic target for this severe childhood infection.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pediatric Infectious Diseases

Background:

  • Staphylococcus aureus pneumonia is a serious childhood infection.
  • Toll-like receptor 2 (TLR2)-mediated inflammation is crucial in S. aureus pneumonia.
  • Krueppel-like factor 9 (KLF9) influences inflammation.

Purpose of the Study:

  • To investigate the role of KLF9 in S. aureus pneumonia.
  • To examine KLF9 expression in relation to age.
  • To determine KLF9's mechanism in regulating inflammation via TLR2.

Main Methods:

  • Measured KLF9 expression in human PBMCs and mouse alveolar macrophages across age groups.
  • Compared inflammatory cytokine responses in young vs. old mice and wild-type (WT) vs. KLF9-deficient macrophages.
  • Assessed survival, lung pathology, and TLR2 expression in WT vs. KLF9-deficient mice post-S. aureus infection.

Main Results:

  • KLF9 expression decreased with age in human PBMCs and mouse macrophages.
  • KLF9 deficiency and aging impaired pro-inflammatory cytokine production.
  • KLF9-deficient mice showed increased survival and reduced lung injury.
  • KLF9 deficiency reduced TLR2 expression, which was rescued by TLR2 overexpression.

Conclusions:

  • KLF9 expression declines with age and is linked to inflammatory responses.
  • KLF9 negatively regulates inflammatory responses in S. aureus pneumonia.
  • KLF9 modulates inflammation through the TLR2 pathway, suggesting KLF9 as a therapeutic target.